Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -90.83% | -48.46% | |||
| Total Other Revenue | -21.43% | -33.33% | |||
| Total Revenue | -88.82% | -48.12% | |||
| Cost of Revenue | -49.17% | 12.72% | |||
| Gross Profit | 6.37% | -524.17% | |||
| SG&A Expenses | -39.60% | 24.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.65% | 14.49% | |||
| Operating Income | 15.73% | -1,680.00% | |||
| Income Before Tax | 18.58% | -5,738.10% | |||
| Income Tax Expenses | 110.94% | -900.00% | |||
| Earnings from Continuing Operations | 13.30% | -8,715.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.30% | -8,715.38% | |||
| EBIT | 15.73% | -1,680.00% | |||
| EBITDA | 14.76% | -6,488.89% | |||
| EPS Basic | 13.53% | -8,706.80% | |||
| Normalized Basic EPS | 18.77% | -4,016.84% | |||
| EPS Diluted | 13.82% | -9,830.00% | |||
| Normalized Diluted EPS | 18.77% | -4,158.51% | |||
| Average Basic Shares Outstanding | 0.26% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.26% | -3.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||